In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Over the last 10 months, the Congress government secured agreements for 140 Life Sciences or pharmaceutical projects ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare's most fundamental tools.

CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus” or the "Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).

The vascular access catheters market, valued at approximately USD 3.0 billion by the end of 2022, is expected to experience ...

"BofA Art market predicts buying opportunities for investors" was originally created and published by Private Banker ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...